Announcements Trials
Browse Landscape

Status

Completed 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 127Observational 4

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 1CNS 1

Conditions

Breast Neoplasms 3Neoplasms 2Neoplasm Metastasis 1Brain Neoplasms 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 405Surgical Procedures, Operative 151Interviews as Topic 131Radiotherapy 130Observation 122Drug Therapy 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 58Watchful Waiting 51Immunotherapy 51Bevacizumab 49Positron Emission Tomography Computed Tomography 46Ultrasonography 44Liquid Biopsy 41Hematologic Tests 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Observational × Lapatinib × Clear all
NCT07416409 2026-02-18

Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer

Deraya University

Completed
80 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT05467189 2022-07-20

Antineoplastic Drugs in Elderly Patients

Shandong University

Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT00898573 2015-10-02

Lapatinib Resistance in Patients With Breast Cancer

Case Comprehensive Cancer Center

Withdrawn
Breast

Breast Neoplasms

NCT00795678 2013-08-02

Chemotherapeutic Agents in Brain/Breast

Case Comprehensive Cancer Center

Completed
10 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡